People with diabetes who used semaglutide or other GLP-1 agonists were also less likely to see a provider for depression.

Meshel Laurie has got candid about her whopping 60kg weight loss as she called for a controversial obesity medication to be added to the Pharmaceutical Benefits Scheme (PBS).

Ozempic and its counterparts, including Wegovy, Mounjaro and Zepbound, have surged in popularity as a means for weight loss, fueled by celebrity endorsements and slick pharmaceutical marketing.

Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

Patients with private insurance face substantial additional monthly out-of-pocket costs following a cancer diagnosis.

Patients face high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with costs increasing with stage of diagnosis, according to a study published in JAMA Network Open.